Skip to main content

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

CD1a promotes systemic manifestations of skin inflammation.

Hardman CS. et al, (2022), Nat Commun, 13

Innate Lymphocyte Mechanisms in Skin Diseases.

Chen Y-L. et al, (2020), 38, 171 - 202

Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells.

Luo J. et al, (2019), J Allergy Clin Immunol, 144, 1722 - 1726.e10

Cutaneous bacterial sensing through group 2 innate lymphoid cell presentation of endogenous CD1a lipid antigens

Hardman C. et al, (2018), BRITISH JOURNAL OF DERMATOLOGY, 178, E403 - E403

Filaggrin inhibits house dust mite phospholipase generation of CD1a lipid antigens for recognition by T cells

Jarrett R. et al, (2016), BRITISH JOURNAL OF DERMATOLOGY, 175, 50 - 50

Interleukin-33, friend and foe in type-2 immune responses.

Hardman C. and Ogg G., (2016), Curr Opin Immunol, 42, 16 - 24

Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase

Jarrett R. et al, (2016), BRITISH JOURNAL OF DERMATOLOGY, 174, E49 - E50

Load More